![Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet](https://www.thelancet.com/cms/asset/787fb81a-bc5b-47fc-8dbc-5e3808361cd0/gr1.jpg)
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - The Lancet
![Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial | Nature Medicine Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01539-8/MediaObjects/41591_2021_1539_Fig1_HTML.png)
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial | Nature Medicine
![HESS - Modelling the hydrological interactions between a fissured granite aquifer and a valley mire in the Massif Central, France HESS - Modelling the hydrological interactions between a fissured granite aquifer and a valley mire in the Massif Central, France](https://hess.copernicus.org/articles/25/291/2021/hess-25-291-2021-avatar-web.png)